Last reviewed · How we verify
NCT05232253
Cystoealstometer (Bladder Monitor Device)-Home Use
NA trial testing Cystoelastometer - Urodynamics Testing in Urinary Bladder, Neurogenic in 30 participants. Participants enrolled and being followed up; not accepting new ones.
1 February 2026
Quick facts
| Lead sponsor | University of Iowa |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 30 |
| Start date | 18 January 2021 |
| Primary completion | 1 February 2026 |
| Estimated completion | 1 February 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cystoelastometer - Urodynamics Testing
Conditions studied
- Urinary Bladder, Neurogenic — all drugs for Urinary Bladder, Neurogenic →
Sponsor
University of Iowa
Who can join
Adults 6 Months to 99, any sex, with Urinary Bladder, Neurogenic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators have developed a novel pressure monitoring device called a 'cystoelastometer' that connects to a drainage end ofastandard urinary catheters that are used by patients with a neurogenic bladder on daily clean intermittent catheterization. The device has already been demonstrated to be accurate in measuring bladder pressure compared to the gold standard urodynamics that are performed in the clinic or hospital. This study will assess the patients and care givers ability and experience using the cystoelastometer device in a home setting.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05232253
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Urinary Bladder, Neurogenic
Currently open trials in the same condition.
- NCT06978205 — Effect of Urethral Balloon Dilatation on Urinary Retention After Spinal Cord Injury · NA · recruiting
- NCT05141487 — Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder · recruiting
- NCT04193709 — Recovery of Bladder and Sexual Function After Human Spinal Cord Injury · NA · recruiting
- NCT03245242 — Pediatric Urology Recovery After Surgery Endeavor (PURSUE) · active not recruiting
Other University of Iowa trials
Trials by the same sponsor.
- NCT07224269 — Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis · EARLY_PHASE1 · not yet recruiting
- NCT07244809 — Probing the Role of Mitochondrial Oxidative Stress in Impaired Vascular Function Among Young Adults With Early Life Adve · NA · recruiting
- NCT07097961 — Paediatric Post-TB Pulmonary Rehab Study · NA · recruiting
- NCT06951594 — Robotic-Assisted Versus Manual Electrode Array Insertion · NA · recruiting
- NCT06710119 — Effect of Custom Dynamic Orthoses on Forefoot Loading · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05232253 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Iowa
- Last refreshed: 6 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05232253.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing